The pandemic's impact on non-COVID research
Non-COVID-19 research has taken a back seat during the pandemic as scientists everywhere scramble to better understand the Sars-CoV-2 virus and develop therapies and vaccines. But it remains important for the scientific community to strongly advocate for sustained investment into non-COVID research. Share your experiences and perspectives to help inform our policy solutions to sustain non-COVID-19 research.
Vice president and director of costing policies, Council on Governmental Relations
Melur K. Ramasubramanian
Vice president for research, University of Virginia
Professor, University Massachusetts Medical School
Who should watch
- Researchers focused on non-COVID research
- Heads of labs
Understand the experience of shutting down and ramping up non-COVID research, funding for non-COVID research, challenges and obstacles to restarting non-COVID research.